Skip to content

Study · Ex vivo tissue · frog · 1991

5 results

Common channels for water and protons at apical and basolateral cell membranes of frog skin and urinary bladder epithelia. Effects of oxytocin, heavy metals, and inhibitors of H(+)-adenosine triphosphatase.

Harvey B, Lacoste I, Ehrenfeld J

The Journal of general physiology1 Apr 1991Cited by 17 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study5

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueMechanism

    In isolated frog skin, oxytocin treatment increased net titratable H+ flux from 30 to 115 neq.h-1.cm-2 at apical pH 5.5.

    In plain wordsIn isolated frog skin, oxytocin increased the flow of protons across the tissue.

    Peptide
    Oxytocin
    Outcome
    IncreaseNet titratable H+ flux across frog skin
    Study

    frogn = 8

    Isolated frog skin and urinary bladder epithelia
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Measurements

    Net titratable H+ flux before oxytocin
    30 neq.h-1.cm-2
    apical pH 5.5, serosal pH 7.4
    Net titratable H+ flux after oxytocin
    115 neq.h-1.cm-2
    apical pH 5.5, serosal pH 7.4

    Source sentences

    Summary
    Net titratable H+ flux across frog skin was increased from 30 +/- 8 to 115 +/- 18 neq.h-1.cm-2 (n = 8) after oxytocin treatment (at apical pH 5.5 and serosal pH 7.4)
    1 context sentence
    Summary · context
    We have compared the response of proton and water transport to oxytocin treatment in isolated frog skin and urinary bladder epithelia to provide further insights into the nature of water flow and H+ flux across individual apical and basolateral cell membranes.
  2. 02LabEx vivo tissueMechanism

    In frog skin principal cells, passive electrogenic H+ transport across the basolateral membrane was not affected by oxytocin.

    In plain wordsIn isolated frog skin, oxytocin did not change proton movement across the lower cell membrane.

    Peptide
    Oxytocin
    Outcome
    No significant changeBasolateral passive H+ transport
    Study

    frogn: not reported in source

    Isolated frog skin and urinary bladder epithelia
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The basolateral membranes of the principal cells in frog skin epithelium were found to be spontaneously permeable to H+ and passive electrogenic H+ transport across this membrane was not affected by oxytocin.
    1 context sentence
    Summary · context
    We have compared the response of proton and water transport to oxytocin treatment in isolated frog skin and urinary bladder epithelia to provide further insights into the nature of water flow and H+ flux across individual apical and basolateral cell membranes.

Studies that did not test the peptide alone3

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 03LabNot a test of Oxytocin aloneEx vivo tissueMechanism

    In frog skin exposed to oxytocin (50 mU/ml), lowering basolateral pH produced a transepithelial current that was blocked by Hg2+, Zn2+, Ni2+ or DCCD; oxytocin served as the condition, and the blockers were tested.

    In plain wordsIn isolated frog skin, an acid-driven current seen with oxytocin present was blocked by several metals and a chemical inhibitor.

    Peptide
    Oxytocin
    Outcome
    Not applicableTransepithelial current at low basolateral pH and block by heavy metals
    Study

    frogn: not reported in source

    Isolated frog skin and urinary bladder epithelia
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Measurements

    Transepithelial current
    3 microA.cm-2
    pHb 5.5, oxytocin 50 mU/ml

    Source sentences

    Summary
    Lowering pHb in the presence of oxytocin (50 mU/ml) produced a transepithelial current (3 microA.cm-2 at pHb 5.5) which was blocked by 100 microM of Hg2+, Zn2+, or Ni2+ at the basolateral side, and by DCCD (10(-5) M) or Hg2+ (100 microM) from the apical side.
    1 context sentence
    Summary · context
    We have compared the response of proton and water transport to oxytocin treatment in isolated frog skin and urinary bladder epithelia to provide further insights into the nature of water flow and H+ flux across individual apical and basolateral cell membranes.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 04LabNot a test of Oxytocin aloneEx vivo tissueMechanism

    In frog bladder sacs, the oxytocin-induced net hydroosmotic water flux was blocked by H+-ATPase inhibitors, including diethylstilbestrol, oligomycin and DCCD in the lumen.

    In plain wordsIn frog bladder tissue, inhibitors of a proton pump stopped the water flow that oxytocin normally causes.

    Peptide
    Oxytocin
    Outcome
    DecreaseOxytocin-induced hydroosmotic water flux and H+-ATPase inhibitors
    Study

    frogn: not reported in source

    Isolated frog skin and urinary bladder epithelia
    Outcome group
    Receptor activity and mechanism · Kidney and urinary

    Source sentences

    Summary
    The net hydroosmotic water flux (JH2O) induced by oxytocin in frog bladder sacs was blocked by inhibitors of H(+)-adenosine triphosphatase (ATPase). Diethylstilbestrol (DES 10(-5) M), oligomycin (10(-8) M), and DCCD (10(-5) M) prevented JH2O when present in the lumen.
    1 context sentence
    Summary · context
    We have compared the response of proton and water transport to oxytocin treatment in isolated frog skin and urinary bladder epithelia to provide further insights into the nature of water flow and H+ flux across individual apical and basolateral cell membranes.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  3. 05LabNot a test of Oxytocin aloneEx vivo tissueMechanism

    In frog bladder sacs, cyanide and 2-deoxyglucose had no effect on the water flux, so the inhibitor effects are not due to metabolic inhibition.

    In plain wordsIn frog bladder tissue, two metabolic blockers did not change the water flow, so the proton pump inhibitors did not act through metabolism.

    Peptide
    Oxytocin
    Outcome
    No significant changeEffect of cyanide and 2-deoxyglucose on water flux
    Study

    frogn: not reported in source

    Isolated frog skin and urinary bladder epithelia
    Outcome group
    Receptor activity and mechanism · Kidney and urinary

    Source sentences

    Summary
    These effects cannot be attributed to inhibition of metabolism since cyanide (10(-4) M), or 2-deoxyglucose (10(-3) M) had no effect on JH2O.(ABSTRACT TRUNCATED AT 400 WORDS)
    1 context sentence
    Summary · context
    We have compared the response of proton and water transport to oxytocin treatment in isolated frog skin and urinary bladder epithelia to provide further insights into the nature of water flow and H+ flux across individual apical and basolateral cell membranes.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.